Ranbaxy moves into Yemen

Ranbaxy Laboratories, India's largest pharmaceutical company, has launched in Yemen. The New Dehli-based generic giant is operating in the country in partnership with Natco Pharma. The formal opening event was attended by R M Aggarwal, Ambassador of India. Ranbaxy intends to expand into the Yemenese market focusing on the anti-infective, gastrointestinal, cholesterol-lowering and anti-allergic areas. It is the first Indian company to establish a major presence in the Middle East, currently active in 11 countries there. The United Arab Emirates is Ranbaxy's major market in the region where it is the leading generic firm. It is also the first Indian company to be registered in Saudi Arabia.